5443192025-11-012026-01-315443192026-01-315443192025-11-012026-01-31Resolution15443192026-01-31Resolution15443192026-01-31Resolution1in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:EVotingMember5443192026-01-31Resolution1in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:TotalVotingMember5443192026-01-31Resolution1in-bse-voting:PublicInstitutionMemberin-bse-voting:EVotingMember5443192026-01-31Resolution1in-bse-voting:PublicInstitutionMemberin-bse-voting:TotalVotingMember5443192026-01-31Resolution1in-bse-voting:PublicNonInstitutionMemberin-bse-voting:EVotingMember5443192026-01-31Resolution1in-bse-voting:PublicNonInstitutionMemberin-bse-voting:TotalVotingMember5443192026-01-31Resolution1in-bse-voting:TotalShareholdingMemberxbrli:purexbrli:shares544319SENORESNOTLISTEDINE0RB801010SENORES PHARMACEUTICALS LIMITEDEGM2026-01-3112:30 PM12:55 PMMukesh H.ShahMukesh H.Shah & Co.CS58272026-01-072026-01-312026-01-2434881129361SpecialtrueTO APPROVE THE ISSUANCE OF 11,70,000 CONVERTIBLE EQUITY WARRANTS BY WAY OF PREFERENTIAL ISSUE ON PRIVATE PLACEMENT BASIS TO PERSONS BELONGING TO THE PROMOTER AND PROMOTER GROUP CATEGORY (“PREFERENTIAL ISSUE”)true211003571027978348.71851027978301000211003571027978348.718510279783010005803847254651543.8763190447164204474.787325.21275803847254651543.8763190447164204474.787325.212719149384528475527.597552847541100019149384528475527.5975528475411000460535881811105339.3261746900864204596.4553.5451076007400